These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9643975)

  • 1. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
    Derebek E
    Eur J Nucl Med; 1998 Apr; 25(4):448. PubMed ID: 9643975
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer: reply.
    Fukushima K; Ishii K; Sakai E
    Eur J Nucl Med; 1998 Jul; 25(7):816-8. PubMed ID: 9741995
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrofosmin thyroid scintigraphy.
    Klain M; Cuocolo A; Salvatore M; Maurea S
    Eur J Nucl Med; 1998 Jul; 25(7):816. PubMed ID: 9741994
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant breast uptake of Tc-99m sestamibi in an actively lactating woman during SPECT myocardial perfusion imaging.
    Ramakrishna G; Miller TD
    J Nucl Cardiol; 2004; 11(2):222-3. PubMed ID: 15052253
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.
    Cwikla JB; Buscombe JR; Barlow RV; Kelleher SM; Parbhoo SP; Crow J; Deery A; Jones AL; Hilson AJ
    Eur J Nucl Med; 1997 Sep; 24(9):1175-8. PubMed ID: 9283114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours.
    Jacobsson H; Wilczek B; Bergh J; von Schoultz E; Eriksson E; Larsson SA
    Nucl Med Commun; 2006 Apr; 27(4):347-52. PubMed ID: 16531920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m sestamibi uptake in the chest mimicking a malignant lesion of the breast.
    Civelek AC; Patel P; Ozalp E; Brem RF
    Breast; 2006 Feb; 15(1):111-4. PubMed ID: 16473742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
    J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
    Line BR; Feustel PJ; Festin SM; Andersen TT; Dansereau RN; Lukasiewicz RL; Zhu S; Bennett JA
    Cancer Biother Radiopharm; 1999 Dec; 14(6):485-94. PubMed ID: 10850335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
    Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
    J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can we expect from MDR breast cancer imaging with sestamibi?
    Palmedo H
    J Nucl Med; 2002 Apr; 43(4):526-30. PubMed ID: 11937597
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m sestamibi uptake in hepatocellular carcinoma.
    Derebek E
    Eur J Nucl Med; 1998 Nov; 25(11):1587-8. PubMed ID: 9882185
    [No Abstract]   [Full Text] [Related]  

  • 15. Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.
    Aloj L; Zannetti A; Caracó C; Del Vecchio S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):521-7. PubMed ID: 14666386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast scintigraphy].
    Prats E; Razola P; García López F; Dolores Abós M; Banzo J
    Rev Esp Med Nucl; 2001 Feb; 20(1):47-70. PubMed ID: 11181333
    [No Abstract]   [Full Text] [Related]  

  • 17. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
    Ballinger JR
    Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
    [No Abstract]   [Full Text] [Related]  

  • 18. Tc-99m sestamibi scintimammography: where is it now?
    Schillaci O; Scopinaro F
    Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
    [No Abstract]   [Full Text] [Related]  

  • 19. Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast.
    Ohta H; Yamamoto S; Ukikusa M; Awane H; Shintaku M; Irie K
    Clin Nucl Med; 1997 Aug; 22(8):553-4. PubMed ID: 9262903
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
    Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF
    J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.